Pharmaceuticals Drugs Medicines

Healthcare Start-Up Leucine Rich Bio Secures Funds In Pre-Series A Funding Round

20/10/2023

The company witnessed 20 per cent YoY growth in 2022-23, while the quarter-on-quarter growth was 30 per cent in the second quarter of the financial year 2023-24